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Figure 2. Glucocorticoid Synthesis and Signaling 
Glucocorticoids (e.g., cortisol) are synthesized from cholesterol in the mitochondria by two 
P450-type enzymes, CYP11B1 and CYPB11B2 and may exert genomic and non-genomic 
effects. Glucocorticoids diffuse through cell membranes and bind with glucocorticoid receptors 
(GR, classic GR and MR, mineralocorticoid receptor).  Glucocorticoid receptors reside in the 
cytoplasm in a multiprotein complex with chaperone proteins, heat shock proteins and 
immunophilins.  The classic GR (specifically GR-α) is the major receptor involved in mediating 
the glucocorticoid responses to stress and inflammation. Upon binding of cortisol, the GR 
undergoes a conformational change that allows it to dissociate from the chaperone proteins and 
translocate into the nucleus and the mitochondria where it binds to glucocorticoid response 
elements (GRE) to activate (transactivation) or repress (cis-repression) pro-inflammatory gene 
expression of various transcription factors (TFs) such as nuclear factor-kappa B (NF-KΒ) and 
activator protein-1 (AP-1).  
